Ever Supreme Bio Technology Co., Ltd (6712.TWO)
TWD 152.5
(-2.24%)
TWD 152.5
(-2.24%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 232.95 Million TWD | 28.39% |
| 2022 | 181.45 Million TWD | 45.36% |
| 2021 | 124.82 Million TWD | 60.94% |
| 2020 | 77.56 Million TWD | 19.61% |
| 2019 | 64.84 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 261.36 Million TWD | -3.2% |
| 2024 Q1 | 270 Million TWD | 15.9% |
| 2023 Q4 | 232.95 Million TWD | 19.15% |
| 2023 FY | 232.95 Million TWD | 28.39% |
| 2023 Q3 | 195.51 Million TWD | 5.8% |
| 2023 Q2 | 184.79 Million TWD | -9.72% |
| 2023 Q1 | 204.69 Million TWD | 12.81% |
| 2022 FY | 181.45 Million TWD | 45.36% |
| 2022 Q4 | 181.45 Million TWD | 0.0% |
| 2021 FY | 124.82 Million TWD | 60.94% |
| 2020 FY | 77.56 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 60.074% |
| Level Biotechnology Inc. | 273.2 Million TWD | 14.73% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -69.026% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | -17.971% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 82.456% |
| GlycoNex Incorporation | 276.39 Million TWD | 15.716% |
| VBI | 21.25 Million TWD | -996.226% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 25.74% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 54.735% |
| Visgeneer Inc. | 185.6 Million TWD | -25.513% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 82.394% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 68.218% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -94.359% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 89.628% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -3420.082% |
| Enimmune corporation | 173.46 Million TWD | -34.299% |
| TaiRx, Inc. | 60.62 Million TWD | -284.262% |
| CHO Pharma, Inc. | 110.83 Million TWD | -110.191% |
| EirGenix Inc. | 1.14 Billion TWD | 79.656% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -108.034% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 54.539% |
| Lin BioScience, Inc. | 167.73 Million TWD | -38.889% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -148.585% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -269.577% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -86.772% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -44.642% |
| RBC Bioscience Corporation | 513.08 Million TWD | 54.596% |
| BiOptic Inc. | 170.56 Million TWD | -36.582% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -452.586% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -901.759% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -768.829% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 76.098% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -3230.841% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -997.517% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 36.753% |
| Neith Corporation | 17.43 Million TWD | -1236.31% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -2822.215% |
| NaviFUS Corp. | 53.4 Million TWD | -336.245% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 51.617% |
| Sinew Pharma Inc. | 39.71 Million TWD | -486.592% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -301.384% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 36.084% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -2.312% |
| AP Biosciences Inc | 106.65 Million TWD | -118.433% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 93.401% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -659.294% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | -18.863% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 84.904% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 73.113% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -2411.417% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -317.392% |
| TCI GENE Inc. | 155.54 Million TWD | -49.767% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -813.278% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -404.513% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 29.078% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -259.023% |
| PharmaEngine, Inc. | 91 Million TWD | -155.982% |
| Savior Lifetec Corporation | 457.95 Million TWD | 49.131% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -109.986% |
| OBI Pharma, Inc. | 650.44 Million TWD | 64.185% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 40.391% |
| Acepodia, Inc. | 384.47 Million TWD | 39.408% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -172.298% |